Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Zeping Zhou, Zhuoqing Qiao, Huiyuan Li, Na Luo, Xian Zhang, Feng Xue & Renchi Yang. (2016) Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases. Autoimmunity 49:1, pages 50-57.
Read now
Read now
Lijuan Luan, Rong Xue, Chao Lu, Anfeng Cui, Yanqiang Hou, Jing Quan, Meng Xiang, Xinhong Wang, Wenjun Yuan, Ning Sun, Dan Meng & Sifeng Chen. (2016) Anti-serum with anti-autoantibody activity decreases autoantibody-positive B lymphocytes and type 1 diabetes of female NOD mice. Autoimmunity 49:1, pages 21-30.
Read now
Read now
Jian Sian Lee, Syed Nasir Abbas Bukhari & Norsyahida Mohd Fauzi. (2015) Effects of chalcone derivatives on players of the immune system. Drug Design, Development and Therapy 9, pages 4761-4778.
Read now
Read now
Arpad Zsigmond Barabas, Chad Douglas Cole, Rene Lafreniere & Donald Mackay Weir. (2012) Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease. Autoimmunity 45:7, pages 495-509.
Read now
Read now
Nima Rezaei, Hassan Abolhassani, Asghar Aghamohammadi & Hans D Ochs. (2011) Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert Review of Clinical Immunology 7:3, pages 301-316.
Read now
Read now
Articles from other publishers (43)
Susana Brun, Jérôme de Sèze & Sylviane Muller. (2022) CIDP: Current Treatments and Identification of Targets for Future Specific Therapeutic Intervention. Immuno 2:1, pages 118-131.
Crossref
Crossref
Callum Howard, Jonathan Sheridan, Leonardo Picca, Wahaj Munir, Nehman Meharban, Prassana Karthik, Mohammed Idhrees, Emmanuel Keddy Momoh & Mohammad Bashir. 2022. Translational Autoimmunity. Translational Autoimmunity
189
228
.
Gunnar Houen. 2022. Therapeutic Antibodies. Therapeutic Antibodies
1
25
.
Ana Suárez-Avellaneda, Jhon H Quintana, Cristian C Aragón, Linda M Gallego, Cindy-Natalia Gallego, Juan D Bolaños, Maria A Guerra, Maria Elena Ochoa, Marcela Granados, Ingrid Ruiz-Ordoñez & Gabriel J Tobón. (2020) Systemic lupus erythematosus in the intensive care unit: a systematic review. Lupus 29:11, pages 1364-1376.
Crossref
Crossref
I Nieto-Aristizábal, T Martínez, M -A Urbano, I Posso-Osorio, I F Plata, J E Garcia-Robledo, C C Aragón, V A Santos & G J Tobón. (2019) Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients. Lupus 28:13, pages 1566-1570.
Crossref
Crossref
Tatiana Martínez, Juan Esteban Garcia-Robledo, Ilich Plata, Maria-Alejandra Urbano, Ivan Posso-Osorio, Lady J. Rios-Serna, María Claudia Barrera & Gabriel J. Tobón. (2019) Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus. Autoimmunity Reviews 18:3, pages 279-286.
Crossref
Crossref
Adrian W. Zuercher, Mel Berger, Reinhard Bolli, Cédric Vonarburg, Martin Spycher, Amgad Shebl, Rolf Spirig, Christoph Kempf, Fabian Käsermann & Sylvia Miescher. 2019. Nijkamp and Parnham's Principles of Immunopharmacology. Nijkamp and Parnham's Principles of Immunopharmacology
327
368
.
Cristina João, Vir Singh Negi, Michel D. Kazatchkine, Jagadeesh Bayry & Srini V. Kaveri. (2018) Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies. The Journal of Immunology 200:6, pages 1957-1963.
Crossref
Crossref
Ekaterina V. Medvedeva, Veronika G. Dmitrieva, Svetlana A. Limborska, Nikolay F. Myasoedov & Lyudmila V. Dergunova. (2017) Semax, an analog of ACTH(4−7), regulates expression of immune response genes during ischemic brain injury in rats. Molecular Genetics and Genomics 292:3, pages 635-653.
Crossref
Crossref
Chaitrali Saha, Mrinmoy Das, Veerupaxagouda Patil, Emmanuel Stephen-Victor, Meenu Sharma, Sandra Wymann, Monika Jordi, Cédric Vonarburg, Srini V. Kaveri & Jagadeesh Bayry. (2017) Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN. Frontiers in Immunology 8.
Crossref
Crossref
Susann Cattepoel, Annette Gaida, Alain Kropf, Marc W. Nolte, Reinhard Bolli & Sylvia M. Miescher. (2016) Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo. PLOS ONE 11:8, pages e0161826.
Crossref
Crossref
Alessandro Prezzo, Filomena Monica Cavaliere, Caterina Bilotta, Metello Iacobini & Isabella Quinti. (2016) Intravenous immunoglobulin replacement treatment does not alter polymorphonuclear leukocytes function and surface receptors expression in patients with common variable immunodeficiency. Cellular Immunology 306-307, pages 25-34.
Crossref
Crossref
Caroline Galeotti, Pushpa Hegde, Mrinmoy Das, Emmanuel Stephen-Victor, Fernando Canale, Marcos Muñoz, Varun K. Sharma, Jordan D. Dimitrov, Srini V. Kaveri & Jagadeesh Bayry. (2016) Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin. Scientific Reports 6:1.
Crossref
Crossref
Andrew R. Crow, Alaa Amash & Alan H. Lazarus. (2015) CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption. Transfusion 55:6pt2, pages 1492-1500.
Crossref
Crossref
Alejandro López-Requena, Oscar R. Burrone & Rolando Pérez. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
407
434
.
Meenu Sharma, Yoland Schoindre, Pushpa Hegde, Chaitrali Saha, Mohan S. Maddur, Emmanuel Stephen-Victor, Laurent Gilardin, Maxime Lecerf, Patrick Bruneval, Luc Mouthon, Olivier Benveniste, Srini V. Kaveri & Jagadeesh Bayry. (2014) Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients. Scientific Reports 4:1.
Crossref
Crossref
Angela S. W. Tjon, Rogier van Gent, Haziz Jaadar, P. Martin van Hagen, Shanta Mancham, Luc J. W. van der Laan, Peter A. W. te Boekhorst, Herold J. Metselaar & Jaap Kwekkeboom. (2014) Intravenous Immunoglobulin Treatment in Humans Suppresses Dendritic Cell Function via Stimulation of IL-4 and IL-13 Production. The Journal of Immunology 192:12, pages 5625-5634.
Crossref
Crossref
Ian K. Campbell, Sylvia Miescher, Donald R. Branch, Patrick J. Mott, Alan H. Lazarus, Dongji Han, Eugene Maraskovsky, Adrian W. Zuercher, Anton Neschadim, Danila Leontyev, Brent S. McKenzie & Fabian Käsermann. (2014) Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils. The Journal of Immunology 192:11, pages 5031-5038.
Crossref
Crossref
Andrea A. Zachary & Mary S. Leffell. (2014) Desensitization for solid organ and hematopoietic stem cell transplantation. Immunological Reviews 258:1, pages 183-207.
Crossref
Crossref
Mitja Luštrek, Peter Lorenz, Michael Kreutzer, Zilliang Qian, Felix Steinbeck, Di Wu, Nadine Born, Bjoern Ziems, Michael Hecker, Miri Blank, Yehuda Shoenfeld, Zhiwei Cao, Michael O. Glocker, Yixue Li, Georg Fuellen & Hans-Jürgen Thiesen. (2013) Epitope Predictions Indicate the Presence of Two Distinct Types of Epitope-Antibody-Reactivities Determined by Epitope Profiling of Intravenous Immunoglobulins. PLoS ONE 8:11, pages e78605.
Crossref
Crossref
Luigi Muratori & Maria Serena Longhi. (2013) The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. Journal of Autoimmunity 46, pages 74-80.
Crossref
Crossref
Arpad Zsigmond Barabas, Chad Douglas Cole, Rene Lafreniere & Donald Mackay Weir. (2013) Regaining Tolerance to a Self-antigen by the Modified Vaccination Technique. Clinical Reviews in Allergy & Immunology 45:2, pages 193-201.
Crossref
Crossref
Andrew R. Crow, Honghui Yu, Dongji Han & Alan H. Lazarus. (2013) Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway. PLoS ONE 8:8, pages e71882.
Crossref
Crossref
Ignacio Rubio-Agusti, Miguel Salavert & Luis Bataller. (2012) Limbic Encephalitis and Related Cortical Syndromes. Current Treatment Options in Neurology 15:2, pages 169-184.
Crossref
Crossref
Lauriane Padet & Renée Bazin. (2013) IVIg prevents the in vitro activation of T cells by neutralizing the T cell activators. Immunology Letters 150:1-2, pages 54-60.
Crossref
Crossref
Nuno Costa, Ana E. Pires, Ana M. Gabriel, Luiz F. Goulart, Clara Pereira, Bárbara Leal, Ana C. Queiros, Wahiba Chaara, Maria F. Moraes-Fontes, Carlos Vasconcelos, Carlos Ferreira, Jorge Martins, Marina Bastos, Maria J. Santos, Maria A. Pereira, Berta Martins, Margarida Lima, Cristina João, Adrien Six, Jocelyne Demengeot & Constantin Fesel. (2012) Broadened T-cell Repertoire Diversity in ivIg-treated SLE Patients is Also Related to the Individual Status of Regulatory T-cells. Journal of Clinical Immunology 33:2, pages 349-360.
Crossref
Crossref
Shivashankar Othy, Patrick Bruneval, Selma Topçu, Isabelle Dugail, Francisco Delers, Sebastien Lacroix-Desmazes, Jagadeesh Bayry & Srini V. Kaveri. (2012) Effect of IVIg on human dendritic cell-mediated antigen uptake and presentation: Role of lipid accumulation. Journal of Autoimmunity 39:3, pages 168-172.
Crossref
Crossref
Danila Leontyev, Yulia Katsman, Xue-Zhong Ma, Sylvia Miescher, Fabian Käsermann & Donald R. Branch. (2012) Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin. Transfusion 52:8, pages 1799-1805.
Crossref
Crossref
Fabian Käsermann, David J. Boerema, Monika Rüegsegger, Andreas Hofmann, Sandra Wymann, Adrian W. Zuercher & Sylvia Miescher. (2012) Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation. PLoS ONE 7:6, pages e37243.
Crossref
Crossref
Gisele Zandman-Goddard, Alexander Krauthammer, Yair Levy, Pnina Langevitz & Yehuda Shoenfeld. (2011) Long-Term Therapy with Intravenous Immunoglobulin is Beneficial in Patients with Autoimmune Diseases. Clinical Reviews in Allergy & Immunology 42:2, pages 247-255.
Crossref
Crossref
A.S. Bansal, B. Bajardeen & M.Y. Thum. (2012) The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. Journal of Reproductive Immunology 93:1, pages 41-51.
Crossref
Crossref
Éric Aubin, Dominic Paquin Proulx, Patrick Trépanier, Réal Lemieux & Renée Bazin. (2011) Prevention of T cell activation by interference of internalized intravenous immunoglobulin (IVIg) with MHC II-dependent native antigen presentation. Clinical Immunology 141:3, pages 273-283.
Crossref
Crossref
David H. Dreyfus. (2011) Autoimmune disease: A role for new anti-viral therapies?. Autoimmunity Reviews 11:2, pages 88-97.
Crossref
Crossref
Mohan S. Maddur, Pushpa Hegde, Meenu Sharma, Srini V. Kaveri & Jagadeesh Bayry. (2011) B cells are resistant to immunomodulation by ‘IVIg-educated’ dendritic cells. Autoimmunity Reviews 11:2, pages 154-156.
Crossref
Crossref
L Padet, I St-Amour, É Aubin & R Bazin. (2011) Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells?. Clinical and Experimental Immunology 166:3, pages 352-360.
Crossref
Crossref
Gerard Espinosa & Ricard Cervera. (2011) Current management of catastrophic antiphospholipid syndrome. International Journal of Clinical Rheumatology 6:3, pages 297-303.
Crossref
Crossref
Jagadeesh Bayry, Emilie M. Fournier, Mohan S. Maddur, Janakiraman Vani, Bharath Wootla, Sophie Sibéril, Jordan D. Dimitrov, Sébastien Lacroix-Desmazes, Mikael Berdah, Yoann Crabol, Eric Oksenhendler, Yves Lévy, Luc Mouthon, Catherine Sautès-Fridman, Olivier Hermine & Srini V. Kaveri. (2011) Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies. Journal of Autoimmunity 36:1, pages 9-15.
Crossref
Crossref
Maria Giovanna Danieli, Lucia Pettinari, Romina Moretti, Francesco Logullo & Armando Gabrielli. (2011) Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application. Autoimmunity Reviews 10:3, pages 144-149.
Crossref
Crossref
Adrian W. Zuercher, Lorenz Amsler, Hanspeter Amstutz, Irmgard Andresen, Reinhard Bolli, Wolfram Hummel, Fabian Käsermann, Christoph Kempf, Peter Lerch, Marius Lötscher, Alexander Schaub, Martin Spycher & Sylvia M. Miescher. 2011. Principles of Immunopharmacology. Principles of Immunopharmacology
271
301
.
Rotem Kedar, Yehuda Shoenfeld & Howard Amital. 2011. Autoimmune Diseases. Autoimmune Diseases
359
374
.
Carlo Selmi. (2010) Autoimmunity in 2009. Autoimmunity Reviews 9:12, pages 795-800.
Crossref
Crossref
B. P. OLIVIERI, R. VASCONCELLOS, A. NÓBREGA, P. MINOPRIO, S. V. KAVERI & T. C. ARAÚJO-JORGE. (2010) Intravenous immunoglobulin increases survival time in the acute phase of experimental Chagas disease. Parasite Immunology 32:6, pages 464-469.
Crossref
Crossref
Caroline Galeotti, Jagedeesh Bayry, Isabelle Kone-Paut & Srinivas V. Kaveri. (2010) Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmunity Reviews 9:6, pages 441-448.
Crossref
Crossref